InterVenn welcomes Andrew Quong, PhD, as CEO!

Site-Specific Glycosylation Quantitation Of 50 Serum Glycoproteins Enhanced By Predictive Glycopeptidomics For Improved Disease Biomarker Discovery

Get in touch